Just when things have calmed down, the drug industry opens a new salvo in its war against bioidentical hormones, perceived as stealing market share from their women’s hormone pill, Prempro, currently in litigation for causing cancer and heart disease. The attack article appeared in the Huffington Post by Phyllis Greenberger, CEO of Society for Women’s Health Research (SWHR), an industry-sponsored mouthpiece that …